pembrolizumab,ziftomenib,abiraterone,cisplatin,ipilimumab,vinflunine,daunorubicin,azacitidine,bevacizumab,carboplatin,cytarabine,atezolizumab,paclitaxel,bms-986253,panitumumab,olaparib,venetoclax,pemetrexed,nivolumab,docetaxel,camrelizumab
merck,roche,jiangsu hengrui pharmaceuticals,kura oncology,pdl,pierre fabre,amgen,takeda,astrazeneca,bms,abbvie
['pembro', 'key,note,789', 'sclc', 'lcsm,(-blcsm)', 'nsclc']
dr. james chih-hsin yang presents keynote 789 study a ph3 trial for metastatic #nsclc with egfrm after tki. pts trx with pemetrex &amp; platin +/- pembro. reslts stat insignificant but pos role for pdl1 to id subset of egfrm pts to benefit from i/o post tki trx. #asco23 #lcsm 
LUNGevity, the nation’s leading lung cancer organization, is transforming what it means to be diagnosed and live with lung cancer.